-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $26

Benzinga·08/03/2026 19:35:37
语音播报
Citigroup analyst Geoff Meacham maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $20 to $26.